Immune-Mediated Hepatitis Induced by Therapy With Alemtuzumab in a Patient With Multiple Sclerosis

Hepatology. 2021 Jan;73(1):460-463. doi: 10.1002/hep.31435. Epub 2020 Dec 14.

Authors

Fabian J Bolte¹, Hartmut H-J Schmidt¹, Bernhard Schlevogt¹

Affiliation

¹ Department of Internal Medicine B, University Hospital Münster, Münster, Germany.

PMID: 32583445
DOI: 10.1002/hep.31435

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Alemtuzumab / adverse effects*
Antineoplastic Agents, Immunological / adverse effects*
Chemical and Drug Induced Liver Injury / etiology*
Chemical and Drug Induced Liver Injury / pathology
Female
Hepatitis / etiology*
Hepatitis / pathology
Humans
Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

Antineoplastic Agents, Immunological
Alemtuzumab